COVID-19 mRNA vaccine (Jiangsu Recbio Technology)

新型冠状病毒奥密克戎变异毒株mRNA疫苗 (江苏瑞科生物)

Report date: 2026/05/13 11:17:40

Base Information

Drug NameCOVID-19 mRNA vaccine (Jiangsu Recbio Technology)

Drug Alias NameCOVID-19 Freeze-drying mRNA vaccine (Jiangsu Rec-Biotechnology)R-520AR-520-A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesJiangsu Rec-Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Rec-Biotechnology Co Ltd

Inactive CompaniesWuhan Recogen Biotechnology Co Ltd

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A